OMX Stockholm 30
2.670,54
PKT
+8,22
PKT
+0,31
%
Werbung
Analysen zu OMX Stockholm 30-Werten
Datum | Rating | Analyst | |
---|---|---|---|
29.06.22 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
28.06.22 | Volvo (B) Sector Perform | RBC Capital Markets | |
24.06.22 | Volvo (B) Buy | Deutsche Bank AG | |
23.06.22 | Volvo (B) Sell | UBS AG | |
23.06.22 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
23.06.22 | Volvo (B) Buy | Jefferies & Company Inc. | |
22.06.22 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
20.06.22 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
20.06.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
20.06.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
17.06.22 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
16.06.22 | Hennes Mauritz (H M, H&M) Overweight | Barclays Capital | |
15.06.22 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
15.06.22 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
15.06.22 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
15.06.22 | Hennes Mauritz (H M, H&M) Neutral | JP Morgan Chase & Co. | |
15.06.22 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
15.06.22 | Hennes Mauritz (H M, H&M) Buy | UBS AG | |
15.06.22 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
14.06.22 | AstraZeneca Neutral | UBS AG | |
13.06.22 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
13.06.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
07.06.22 | AstraZeneca Outperform | Credit Suisse Group | |
07.06.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
06.06.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
06.06.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
06.06.22 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
27.05.22 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
27.05.22 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
27.05.22 | Hennes Mauritz (H M, H&M) Overweight | Barclays Capital | |
26.05.22 | Hennes Mauritz (H M, H&M) Neutral | JP Morgan Chase & Co. | |
25.05.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
25.05.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
24.05.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
24.05.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
24.05.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
23.05.22 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
19.05.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
19.05.22 | AstraZeneca Buy | Deutsche Bank AG | |
19.05.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.